We are very excited to share results from a recent head-to-head study. This independent 228-patient randomized controlled clinical trial published in the Journal of Psychiatric Research showed that our Deep TMS System, combined with medication, is significantly superior to medication alone for treating major depressive disorder.
The remission rate for both the dTMS (H1-coil) group (59.7%) and the standard rTMS (figure 8-coil) group (42.7%) was significantly higher than with the control group (11.1%) in the ITT population
The response rate was significantly greater with dTMS plus pharmacotherapy (66.7%) than with standard rTMS plus pharmacotherapy (44.0%)
The mean reduction of HAM-D17 was 59% in the dTMS group, 41% in the standard rTMS group, and 17% in the control group